Leukemia  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00062296: Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Completed
2
5
US
rituximab, epirubicin hydrochloride
Fox Chase Cancer Center, National Cancer Institute (NCI)
Leukemia, Lymphoma
08/05
08/05
NCT06140966: Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

Recruiting
2
54
RoW
Daratumumab, Darzalex, Carfilzomib, Kyprolis, Lenalidomide, Revlimid, Dexamethasone, Baycadron, Cisplatin, Platinol, epirubicin, Pharmorubicin, Cyclophosphamide, Cytoxan, Etoposide, Eposin, Melphalan, Alkeran, ASCT, autologous stem cell transplantation, bortezomib, Velcade
Wuhan Union Hospital, China
Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma
10/26
10/27
NCT03286634: ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

Recruiting
2
60
Japan, RoW
Daunorubicin, DNR, Prednisolone, Pred, Vincristine, VCR, Epirubicin, EPI, E-coli L-asparaginase, E-coli L-Asp, 6-Mercaptopurine, 6-MP, Methotrexate, MTX, Hydrocortisone, Cytarabine, Ara-C, Cyclophosphamide, Cy
National Hospital Organization Nagoya Medical Center
Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer
03/28
03/33

Download Options